7th Jul 2020 13:43
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1) | Barclays PLC. | |
Company dealt in | AON PLC | |
Class of relevant security to which the | ORD | |
dealings being disclosed relate (Note 2) | ||
Date of dealing | 06 July 2020 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
Class of relevant security: | ORD | ||||
Long | Short | ||||
Number | (%) | Number | (%) | ||
(1) | Relevant securities | ||||
237,489 | 0.10% | 1,476,504 | 0.64% | ||
(2) | Derivatives (other than options): | ||||
521,650 | 0.23% | 29,700 | 0.01% | ||
(3) | Options and agreements to | ||||
purchase/sell: | 2,600 | 0.00% | 4,500 | 0.00% | |
TOTAL: | |||||
761,739 | 0.33% | 1,510,704 | 0.65% | ||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale | Number of relevant securities | Price per unit |
Purchase | 4 | 193.4100 USD |
Purchase | 5 | 192.7200 USD |
Purchase | 7 | 193.0200 USD |
Purchase | 8 | 192.3825 USD |
Purchase | 13 | 193.5100 USD |
Purchase | 14 | 193.5900 USD |
Purchase | 19 | 192.4400 USD |
Purchase | 32 | 193.1665 USD |
Purchase | 72 | 193.6900 USD |
Purchase | 100 | 192.7600 USD |
Purchase | 100 | 192.6900 USD |
Purchase | 134 | 192.7474 USD |
Purchase | 199 | 193.2471 USD |
Purchase | 201 | 193.9100 USD |
Purchase | 313 | 193.9068 USD |
Purchase | 351 | 192.6558 USD |
Purchase | 400 | 193.0312 USD |
Purchase | 419 | 192.9704 USD |
Purchase | 419 | 192.7056 USD |
Purchase | 514 | 193.9080 USD |
Purchase | 551 | 192.7371 USD |
Purchase | 3,466 | 192.7000 USD |
Purchase | 3,580 | 192.6281 USD |
Purchase | 3,971 | 192.8727 USD |
Purchase | 6,014 | 193.5904 USD |
Purchase | 6,807 | 193.3516 USD |
Purchase | 8,300 | 193.0594 USD |
Purchase | 8,600 | 193.0482 USD |
Purchase | 35,687 | 193.0782 USD |
Sale | 14 | 193.5900 USD |
Sale | 16 | 192.4400 USD |
Sale | 34 | 192.5800 USD |
Sale | 68 | 192.6050 USD |
Sale | 72 | 192.9073 USD |
Sale | 100 | 193.6500 USD |
Sale | 100 | 193.8400 USD |
Sale | 100 | 193.0500 USD |
Sale | 100 | 193.6800 USD |
Sale | 108 | 193.7137 USD |
Sale | 136 | 192.6575 USD |
Sale | 140 | 192.6900 USD |
Sale | 148 | 193.4237 USD |
Sale | 155 | 193.2512 USD |
Sale | 190 | 192.5652 USD |
Sale | 200 | 193.1200 USD |
Sale | 201 | 193.7131 USD |
Sale | 289 | 193.0038 USD |
Sale | 291 | 193.2570 USD |
Sale | 294 | 193.2082 USD |
Sale | 296 | 192.8893 USD |
Sale | 305 | 192.4970 USD |
Sale | 340 | 192.6000 USD |
Sale | 372 | 193.4569 USD |
Sale | 372 | 193.4184 USD |
Sale | 400 | 193.1775 USD |
Sale | 489 | 192.6015 USD |
Sale | 500 | 193.2560 USD |
Sale | 514 | 193.9080 USD |
Sale | 546 | 193.1360 USD |
Sale | 550 | 192.6402 USD |
Sale | 622 | 192.6968 USD |
Sale | 748 | 192.6527 USD |
Sale | 1,013 | 193.1897 USD |
Sale | 1,200 | 193.6052 USD |
Sale | 1,292 | 193.4948 USD |
Sale | 1,300 | 193.3019 USD |
Sale | 1,823 | 193.1917 USD |
Sale | 2,846 | 193.7357 USD |
Sale | 4,210 | 193.0969 USD |
Sale | 4,636 | 192.7000 USD |
Sale | 7,348 | 193.0031 USD |
Sale | 7,500 | 192.9706 USD |
Sale | 7,851 | 192.8545 USD |
Sale | 12,432 | 193.1144 USD |
Sale | 18,745 | 193.1387 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 6) | Number of relevant securities (Note 7) | Price per unit (Note 5) |
|
|
|
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
Is a Supplemental Form 8 (Open Positions) attached? | YES |
Date of disclosure: | 7 Jul 2020 |
Contact name: | Large Holdings Regulatory Operations |
Telephone number: | 020 3134 7213 |
If a connected EFM, name of offeree/offeror with which connected |
|
If a connected EFM, state nature of connection |
|
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
Product name | Written or | Number of | Exercise | Type | Expiry |
purchased | relevant securities | price | date | ||
to which the option | |||||
or derivative | |||||
relates | |||||
Call Options | Purchased | 1,100 | 260.0000 | American | Jul 17, 2020 |
Call Options | Purchased | 1,500 | 240.0000 | American | Jul 17, 2020 |
Call Options | Written | -4,500 | 220.0000 | American | Jul 17, 2020 |
Notes
1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200707005517/en/
Copyright Business Wire 2020
Related Shares:
Aon Cl A OrdBarclays